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Abstract
The enzymes of the protein disulfide isomerase (PDI) family are thiol–disulfide oxidoreductases of the endoplasmic reticulum (ER). They contain
a CXXC active-site sequence where the two cysteines catalyze the exchange of a disulfide bondwith or within substrates. The primary function of the
PDIs in promoting oxidative protein folding in the ER has been extended in recent years to include roles in other processes such as ER-associated
degradation (ERAD), trafficking, calcium homeostasis, antigen presentation and virus entry. Some of these functions are performed by non-catalytic
members of the family that lack the active-site cysteines. Regardless of their function, all human PDIs contain at least one domain of approximately
100 amino acid residues with structural homology to thioredoxin. As we learn more about the individual proteins of the family, a complex picture is
emerging that emphasizes as much their differences as their similarities, and underlines the versatility of the thioredoxin fold. Here, we primarily
explore the diversity of cellular functions described for the human PDIs.
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Disulfides are covalent bonds produced by oxidation of two
free thiols — in proteins they form between two cysteine res-
idues. They serve important functions during protein folding
and in stabilizing protein structures – both as intramolecular
bonds and when formed intermolecularly between two protein
chains – but also through their capacity to work as regulatory
switches in redox signaling.
Mammalian cells produce a fascinating collection of com-
plicated disulfide-bonded structures. Disulfides are present in a
large fraction of the close to 1 /3 of all human proteins that
traverse the secretory pathway [1]. The synthesis and folding of
these proteins take place in the ER where the environment is
conducive to disulfide-bond formation — the ER lumen is rel-
atively more oxidizing than the cytosol, and a number of en-
zymes catalyze the formation of native disulfides. This activity
was first shown for PDI [2] that is an abundant protein of the ER
and the founding member of the PDI family (the members
of which we refer to as PDIs). It is an essential protein in
S. cerevisiae [3], and the human as well as the yeast protein have⁎ Corresponding author. Tel.: +45 35 32 17 25; fax: +45 35 32 15 67.
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doi:10.1016/j.bbamcr.2007.11.010been thoroughly investigated in vitro. Based on these and
similar studies on other family members, we now have a quite
detailed understanding of the structure and enzymatic properties
of single catalytically active thioredoxin-like domains, the basic
unit of PDIs. As the name implies, these domains are structural
homologs of the cytosolic reductase thioredoxin.
Current work is directed at understanding the interplay
between domains within the multi-domain structure found in
most PDIs. For PDI itself, the domain composition has been
known for years [4–6] and recently the crystal structure of the
entire protein from S. cerevisiae, Pdi1p, was solved [7] (Fig. 1A
and B). Another center of attention is the physiological function
of individual proteins, including studies of their cellular redox
regulation and the identification of endogenous substrates. To-
gether, these topics also constitute the main focus of this review,
where we will limit ourselves to the mammalian system and the
processes that take place in the ER unless directly otherwise
stated (for recent studies on the extracellular function of P5 and
ERp57 see [8,9]).
2. The proteins of the human PDI family — an overview
With the increasing number of cDNA sequences deposited in
the public domain in recent years, the number of known human
Fig. 1. Domain composition and three-dimensional structure of PDI. A,
schematic overview of the PDI domain composition. Thioredoxin-like domains
are shown as rounded rectangles with purple lettering denoting catalytic
domains (a and a′) and green lettering non-catalytic domains (b and b′). The
active-site sequences are shown. The C-terminal extension beyond the a′
domain constitutes the prominent α-helix visible at the C-terminus in the crystal
structure of Pdi1p (B). The α-helices are shown in red, β-strands in yellow and
loops in green. The active-site cysteines are depicted as purple spheres.
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published members that all contain a predicted signal sequence
and at least one thioredoxin-like domain (Table 1)[10–12].Table 1
Overview of the proteins of the human PDI family listed according to size with the
The lengths include the predicted signal sequence and the grey coloring of thiore
been solved. The assignment of domains is based on previously published data and
aPDB accession numbers are given only for structures of metazoan proteins with th
bThe ER localization of Hag2 and Hag3 has been confirmed for myc-tagged variant
cThe names ERp28 and ERp29 are often used interchangeably in the literature, altho
dERp46 is also known as EndoPDI.
eThe ER localization for TMX2 has not been experimentally confirmed. Moreover,
n.a. — not applicable.Although the family name implies an isomerase function, this
activity has not been demonstrated experimentally for all. PDILT
has been shown not to have any appreciable oxidoreductase
activity [13], which probably also holds true for other PDIs with
only one cysteine in the active site, such as the newly discovered
Hag2 and Hag3 [14]. Moreover, ERp27 and ERp29 are non-
catalytic family members. It is therefore important to stress that
the grouping of proteins into the human PDI family is not based
on one common function or the exact same enzymatic proper-
ties, but rather on sequence and structural similarity as well as
ER localization (see below).
Table 1 provides an overview of important traits of the human
PDIs. The unifying feature in terms of sequence and structure is
the thioredoxin-like domains that can be either catalytic or non-
catalytic. By convention these two types of domains are called
a- and b-type domains, respectively. The a-type domains usually
contain two cysteines in a CXXC active-site motif with an
intervening GH sequence being the most common in the PDIs.
By sequence similarity rather than catalytic activity some
domains lacking one or even two active-site cysteines are also
categorized as a-type domains (Table 1). The b-type domains do
not have cysteines in the active site and are therefore not redox
active. Generally, the sequence similarity is much higher for a-
type than b-type domains since the latter are missing a number of
residues important for catalysis that are conserved among the a
domains. Only two PDIs contain additional types of domains in
the ER — ERdj5 has an N-terminal J-domain that binds and
stimulates the ATPase activity of the ER chaperone BiP in vitro
[15,16], and ERp29 comprises an α-helical so-called D-soluble proteins above the thick line and the transmembrane proteins below
doxin-like domains denotes those for which a three-dimensional structure has
our own bioinformatics analysis. J: J-domain, D: D-domain.
e exception of the Pdi1p protein from S. cerevisiae.
s of both proteins (Ruddock, L., personal communication).
ugh the human protein was originally named ERp28 and the rat protein ERp29
it is unclear whether its thioredoxin-like domain faces the ER or the cytosol..
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– contains a binding site for its substrate [17,18].
Most human PDIs are soluble proteins with a C-terminal
KDEL-like ER-localization motif. Although ERp44 is also found
in the ER, it primarily localizes to the ER-Golgi intermediate
compartment (ERGIC) and cis-Golgi despite its C-terminal
RDEL sequence [19–21]. Four PDIs are transmembrane proteins
of the TMX (for “thioredoxin-related transmembrane protein”)
subgroup. TMX2 and TMX3 have typical C-terminal KKXXER-
localization motifs. However, no localization study has been
published for TMX2. In TMX4, two arginines of a cytosolic RQR
sequence play a key role in retaining the protein in the ER (Roth,
D. and Ellgaard, L., unpublished data). A similar RQR sequence
is also present in TMX.
3. Catalytic properties
The redox activity of the PDI enzymes is governed by the
CXXC active site. When in the oxidized state, the disulfide can
be transferred to the substrate to catalyze its oxidation whereby
the active site itself becomes reduced. When in the reduced
state, substrate disulfides can be reduced and the active site
ends up in the oxidized state. These thiol–disulfide exchange
reactions proceed through the formation of a transient mixed
disulfide between enzyme and substrate (Fig. 2). Since re-
duction requires the second cysteine to resolve the mixed
disulfide with the substrate, mutation of this residue leads to theFig. 2. Mechanism of thiol–disulfide exchange reactions. Thiol–disulfide
exchange reactions between disulfide (S–S) donor and acceptor proteins occur
via two cysteine residues in each protein (only depicted by the sulfur atom, S). In
the first step, one cysteine in the disulfide acceptor is deprotonated to form a
reactive thiolate anion, which in turn attacks the disulfide bond between the two
cysteines in the disulfide donor. This leads to the formation of a transient mixed
disulfide between the two proteins that is released by the attack of a thiolate anion
derived from the second cysteine in the disulfide acceptor. The reaction is
completed by the protonation of the resulting thiolate anion in the disulfide donor.
Catalytic PDIs harboring a CXXC active-site sequence are specialized disulfide-
carrier proteins that act both as disulfide-donor and -acceptor enzymes, i.e.
catalyzing both cysteine oxidation and disulfide reduction in their substrates.
Disulfide isomerization reactions catalyzed by PDI family members (not
depicted) proceed through the same basic reaction chemistry as thiol–disulfide
exchange reactions. Isomerizations involve at least one further cysteine in the
substrate and typically end up with no net thiol–disulfide exchange between PDI
family member and substrate [26].accumulation of covalent complexes through an intermolecular
disulfide [22,23].
The PDIs also catalyze the rearrangement of wrongly formed
disulfides in the process called isomerization. Since non-native
disulfides are often formed during folding and prevent the
formation of the native structure [24], isomerization is a crucial
reaction. Mechanistically, it can take place by rounds of reduction
(of the non-native disulfide) and oxidation (to introduce the
correct pairing of cysteines) [22,25]. Isomerization can also occur
within the substrate molecule while bound to the enzyme through
a mixed disulfide. When initiated from the reduced state of the
enzyme the intramolecular isomerization pathway involves no
thiol–disulfide exchange. In principle, the process can also be
initiated from the oxidized state, in which case it can be mecha-
nistically coupled to substrate oxidation [26].
The reactive species in thiol–disulfide exchange reactions is
the thiolate anion (Fig. 2). In thiol–disulfide oxidoreductases,
the N-terminal cysteine of the CXXC motif generally has a low
pKa-value that allows its deprotonation at physiological pH. The
thermodynamic stability of the active-site disulfide, i.e. the
redox potential, is obviously a determining factor for the re-
dox activity performed by the enzyme. The redox potential is
influenced by a variety of sequence characteristics, and the
catalytic properties of single domains are modulated by these
traits [10]. Still, all CXXC-containing PDIs tested so far have
been able to catalyze thiol–disulfide exchange in vitro (see for
instance [27–31]).
Single thioredoxin-like domains can catalyze oxidation and
reduction [32–34]. For the more complex isomerization re-
action, single domains (or mixtures of these) of PDI and ERp57
are poor catalysts and the entire molecules are required for full
activity [32,33,35]. Moreover, PDI is a significantly better
isomerase than ERp57 and P5 [30,33]. In addition to low-
affinity binding sites in the a and a′ domains [36], a binding site
in the b′ domain of PDI is required, but not sufficient, for
efficient binding of larger peptides and misfolded proteins
[37,38]. The preference of these three binding sites for hy-
drophobic sequences explains the broad substrate specificity for
non-native proteins observed for PDI, and results in efficient
and dynamic association with substrates [26]. By the affinity for
partially unfolded polypeptide chains, PDI can either gain ac-
cess to buried thiols or disulfides in substrate proteins and
catalyze their oxidation, reduction or isomerization, or chaper-
one a folding intermediate by inhibiting aggregation [39–41].
The relation between substrate binding and catalytic activity is
significantly less well characterized in other PDIs, with the
exception of ERp57 (see Section 6.1.2).
4. Structure–function relations
The first structure solved at atomic resolution for a human
PDI was that of the PDI a domain (PDIa) [42]. This structure
shows a number of features characteristic for redox-active
domains of the entire family and has clearly helped improve our
understanding of how the PDIs function. The secondary struc-
ture elements are arranged in a β1-α1-β2-α2-β3-α3-β4-β5-α4
fashion [43,44]. The residues of the active site are positioned at
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site cysteines partially surface exposed. Other key features
include a hydrophobic patch found in the vicinity of, as well as a
loop containing a proline in the cis-conformation positioned
close to the active site, with both traits implicated in substrate
binding (see for instance [42,45,46]).
Structures are now known for a substantial number of single
redox-active domains from mammalian PDIs (Table 1). In par-
ticular, the RIKEN Structural Genomics Initiative has deposited
several such (unpublished) NMR structures in the PDB da-
tabase. Most structures solved are from closely related domains
with the common CGHC active-site sequence. The proteins
containing these domains behave similarly with respect to
reaction kinetics, pH dependence and the nature of the rate-
limiting step in an in vitro peptide oxidation assay [27]. Not
surprisingly, examination of the structures reveals only very
minor variation from the thioredoxin fold of PDIa and the
general features known to be important for activity are conserved
throughout. While these structures will be useful for molecular
modeling purposes, we predict that only limited insight of gen-
eral importance will be gained from solving additional three-
dimensional structures of conventional redox-active thioredoxin-
like domains in isolation.
By far most of the human PDIs are multi-domain proteins that
contain thioredoxin-like domains of both the a- and b-types
present in different arrangements (Table 1). The recent crystal
structures of full-length Pdi1p [7] and ERp57bb′ [47] have
provided the first exciting information about the three-dimen-
sional domain organization of these proteins. The structure of
Pdi1p shows a U-shaped molecule with a base formed by the b
and b′ domains, and the arms by the two redox-active domains
(Fig. 1B). Small angle X-ray scattering of full-length ERp57
showed that the overall shape of the two proteins is highly
similar [47]. A continuous hydrophobic region characterizes
the surface of the bb′ fragment in Pdi1p and creates a plat-
form for interaction with unfolded polypeptides. The surface of
ERp57bb′ contains a highly conserved positively charged patch
that constitutes the binding site for the negatively charged
P-domain of calnexin (CNX) and calreticulin (CRT), the two
lectin chaperones that govern substrate binding of ERp57 to
glycoproteins (see Section 6.1.2) [48–53]. The positively
charged residues in ERp57b′ that contact the P-domain are
found in a position equivalent to the active site in redox-active
a-type domains [47].
Overall, the b-type domains serve a number of functions
within the multi-domain structures of PDIs. As observed for
ERp57b′, a substrate-binding pocket in the fruitfly ortholog of
ERp29 has beenmapped to a position corresponding to that of the
active site in a-type domains [54]. At least certain non-catalytic
domains might therefore have evolved to bind either substrates or
co-factors in a similar manner [10,11,55]. The b-type domains
have an additional structural role in positioning the catalytic
domains favorably for interaction with substrates or regulators
such as the oxidase Ero1. Thus, work on Pdi1p shows that only
within the context of the full-length protein are the a and a′
domains recognized differentially by Ero1 with the a′ domain
being the preferred substrate [56]. Recent work shows that b-typedomains also structurally stabilize neighboring a-type domains
[57].
5. Redox regulation of the human PDIs
The tripeptide glutathione constitutes the primary cellular
redox buffer. With a cysteine in the middle position it can exist
in a reduced (GSH) and a dimeric oxidized (GSSG) form. Many
enzymatic studies on PDIs have been performed in vitro using
glutathione redox buffers made up to mimic the redox con-
ditions of the ER lumen. These are relatively more oxidizing
than in the cytosol [58], but the physiologically relevant value
of the [GSH]2:[GSSG] relation is not known. Furthermore,
PDIs function in the context of the ER environment, and the
conditions in the ER are vastly different from any test tube
solution. For instance, the in vivo redox state of a given PDI is
not only determined by its redox potential and the glutathione
redox buffer in the ER, but is also modulated by the presence of
oxidases, potential reductases and substrates, their availability
and the kinetics of reaction.
A major pathway for the generation of disulfide bonds in
the ER of human cells involves the FAD-binding oxidases
Ero1α and Ero1β [59,60]. Work on the better characterized
ortholog in S. cerevisiae, Ero1p, shows that it uses the oxidative
equivalents from the conversion of molecular oxygen to hydro-
gen peroxide to specifically oxidize a subset of yeast PDIs in a
thiol–disulfide exchange reaction [61–63]. It is reasonable to
assume that the human Ero1 enzymes fulfill the same function
since their overexpression significantly increases the fraction of
oxidized PDI [64,65] (Appenzeller-Herzog, C. and Ellgaard, L.,
unpublished data). Therefore, the oxidized fractions of ∼34%
of PDIa and ∼31% of PDIa′ in endogenous PDI at steady-state
[66] likely result in part from the activity of Ero1.
Given the high intracellular glutathione concentration [67]
and the many in vitro studies showing efficient thiol–disulfide
exchange between PDIs and glutathione (see for instance
[32,68–71]), it is not surprising that the redox state of PDIs also
depends on the [GSH]2:[GSSG] relation in the ER. In particular,
a reductive pathway has been uncovered, where GSH from the
cytosol crosses the ER membrane by facilitated diffusion [72–
75]. Consequently, the active sites of PDIs are reduced by GSH,
a reaction that – while also competing with protein thiols in
folding substrates – generates GSSG and hence contributes to
the formation of the glutathione redox buffer in the ER (Fig. 3).
The in vivo redox state of ERp57 and other PDIs has been
published to be in the reduced state [74]. More recently, it has
been observed that TMX3 [28,66] and several other family
members including ERp57 [76] (Appenzeller-Herzog, C., Roth,
D. and Ellgaard, L., unpublished data) are partially oxidized in
vivo. Although, as pointed out above, a redox equilibrium
between PDIs and the glutathione redox buffer in the ER cannot
be assumed, the moderate redox potentials measured for the
PDIs investigated to date of around −160 mV are consistent
with the occurrence of their active sites in both the reduced and
oxidized state in the ER [28,33,68,77]. Concerning a possible
influence of Ero1, co-immunoprecipitation of PDIs with Ero1α
has failed to detect any homolog of PDI in complex with Ero1α,
Fig. 3. Graphical overview of electron flow pathways to and from PDIs. The
redox state of a PDI given by the ratio of oxidized (ox) and reduced (red) active
sites is governed by opposing thiol–disulfide exchange reactions. While reduced
PDIs can be oxidized by oxidized Ero1 that ultimately transfers the electrons
(2e−) onto molecular oxygen (O2) (black arrows), oxidized PDIs can react with
GSH or reduced substrates (grey arrows). The electron fluxes associated with the
formation of GSSG and oxidized substrates (blue arrows) lead to the
stoichiometric generation of hydrogen peroxide (H2O2). For simplicity,
reduction of substrates by (reduced) PDIs is omitted from the scheme, and
only the net flow of electrons from nascent polypeptide substrates onto PDIs is
depicted.
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However, since mixed disulfides are very difficult to trap, this
negative result does not exclude the possibility that family
members other than PDI are also subject to Ero1-mediated oxi-
dation. Indeed, indirect evidence points to ERp57 as a potential
substrate for Ero1, since Ero1p oxidizes ERp57 in vitro [56],
CXXS active-site mutants of ERp57 trap Ero1α in a mixed-
disulfide complex [78], and overexpression of ERp57 in tissue-
culture cells helps retain overexpressed Ero1α in the cell as is
the case for PDI [79].
As indicated in Fig. 3, uncontrolled active-site oxidation by
Ero1 followed by reduction via GSH would set up a futile cycle
resulting in the generation of hydrogen peroxide and GSSG in
the ER [80]. Therefore, in analogy to the situation in yeast [81], it
is conceivable that under hyperoxidizing conditions a feedback
mechanism negatively regulates Ero1 also in mammalian cells.
Overall, Ero1 and GSH (or reduced substrates) play opposing
roles in the control of the redox state of PDIs (Fig. 3), whereas
the extent of Ero1-mediated oxidation of particular PDIs remains
to be determined.
6. Discrete and redundant functions in protein maturation
The relative ease of recombinantly expressing the human
PDIs and performing assays of thiol–disulfide exchange ac-
tivity has promoted their in vitro characterization. In contrast,
the cellular characterization is technically more challenging and
not nearly as advanced. Functional information has been ob-
tained by various co-immunoprecipitation tactics, secretion or
folding studies under conditions of knockout or knockdown
of single PDIs, and – more indirectly – by complementing the
lethal ΔPDI1 mutation in yeast with human PDI genes.
Problems associated with the in vivo investigation of PDIs
include the transient nature of the mixed-disulfide complexes
with substrates that makes it hard to identify the latter and at
least a certain redundancy among PDIs. Still, data on the
oxidative folding of specific substrates by the PDIs are now
emerging more rapidly as the field starts to address these aspectsmore directly (Section 6.1). In addition, we will cover the more
specialized functions that certain PDIs fulfill in maturation and
ER retention (Section 6.2).
6.1. Oxidative folding pathways
6.1.1. PDI
The importance of PDI in oxidative folding was originally
illustrated by the finding that reconstitution of microsomes
depleted of luminal proteins with purified PDI reverses their
defect in co-translational disulfide-bond formation [82]. Still, in
comparison to the wealth of information on the structure and
enzymatic properties of PDI, we know very little about its
involvement in specific protein maturation pathways in vivo.
This reflects the special difficulties in investigating PDI. Since
the protein is likely essential as is the case in yeast [3,83],
knockout cell lines do not exist, while RNAi studies are
complicated by the cytotoxic effects of PDI silencing on the one
hand [84] and the high abundance and long half-life of the
protein on the other [85,86]. Moreover, owing to its broad
substrate specificity PDI is expected to bind so many proteins in
the ER that a cross-linking/co-immunoprecipitation strategy to
identify in vivo substrates is difficult to perform. Apart from the
procollagens, where PDI plays well-studied specific roles
during maturation (see Section 6.2.1), only few examples of
bona fide PDI substrates are known. Nevertheless, a number of
potential substrates have been identified by cross-linking fol-
lowed by immunoprecipitation using substrate-specific anti-
bodies (for examples see [87–91]), and transient disulfide-
bonded complexes between PDI and Semliki Forest virus
glycoprotein E1 representing co- and post-translational folding
intermediates have been trapped [92]. Moreover, PDI partici-
pates in the oxidative folding of thyroglobulin [93] (see Section
6.1.4).
6.1.2. ERp57
The specificity of substrate binding by ERp57, the closest
homolog of PDI, is one of the best-resolved issues in the func-
tional characterization of the PDI family [94]. As a result of its
interaction with the two related, ER lectin chaperones CNX and
CRT [50–52,94](see also Section 4) ERp57 acts on glycosylated
substrates [92,95]. Pharmacological interference with substrate
binding by CNX and CRT (e.g. by castanospermine, an inhibitor
of glycan trimming) also potently prevents the interaction of
ERp57 with glycoproteins [92,95].
ERp57 is a multifunctional oxidoreductase that readily
catalyzes dithiol oxidation, disulfide isomerization, and reduc-
tion in vitro [33,34,96]. Functional data suggest that it catalyzes
all of these reactions in the ER as well. A potential role in
oxidation comes from the finding that early oxidative folding of
Major Histocompatibility Compex (MHC) class I heavy chain
(HC) [97] and CD1d [98] is delayed upon inactivation of ERp57
by treatment with siRNA or castanospermine, respectively.
More specifically, both studies reported impaired formation of
only one of the two disulfides present in mature HC and CD1d,
while the other disulfide was formed more rapidly and in an
ERp57-independent way. In HC, the ERp57-dependent
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The same domain and the same disulfide are strictly conserved
in CD1d pointing to a conserved specific engagement of ERp57
during oxidative folding of α3 domains.
A role of ERp57 in thiol oxidation is also supported by its
presence in mixed-disulfide intermediates at early time points of
substrate folding. Very much like thyroglobulin [93] (Section
6.1.4), the Semliki Forest virus glycoprotein p62 is engaged co-
translationally into mixed-disulfide complexes with ERp57
[92,99]. Likewise, cross-linking of in vitro-translated tyrosinase
in semi-permeabilized melanocytes has revealed an early role of
ERp57 (but not PDI) that was concomitant with disulfide-bond
formation in the nascent polypeptide chain [100]. Taken to-
gether, it is fair to assume that ERp57 operates directly in sub-
strate oxidation in vivo.
The in vivo function of ERp57 as a disulfide reductant has
recently been highlighted by the preparative isolation of mixed-
disulfide binding partners of overexpressed, tagged ERp57 [78].
Efficient co-immunoprecipitation was achieved by mutating the
C-terminal cysteines of both active sites in ERp57. Active sites
mutated in this manner can only trap substrates for reduction
[26]. Still, 26 potential glycoprotein substrates were identified
[78]. Due to the detection limits of the experiment, this does
probably not cover the full spectrum of reduction substrates for
ERp57. The finding that some proteins were also trapped in cells
treated with castanospermine may reflect a non-physiological
reactivity of themutated ERp57 or point to a glycan-independent
substrate recognition mode of ERp57. Interestingly, the trapped
proteins showed a statistical over-representation of small,
disulfide-rich domains with a low level of secondary structure
that might be especially prone to formation of non-native
disulfide bonds during folding. Two of the identified interactors,
clusterin and β1 integrin, were further shown to require ERp57
for efficient oxidative folding with evidence found in both cases
for a role of ERp57 in reducing incorrect disulfide bonds [78].
Posttranslational reshuffling of disulfides by ERp57 has been
demonstrated for three viral proteins, although ERp57 was
essential for oxidative folding of only one of these, influenza
virus hemagglutinin [99]. Furthermore, the role of ERp57 in
protecting cells against ER stress-induced apoptosis elicited by
misfolded proteins [101,102] most probably reflects its activity
to resolve non-native, deleterious disulfide bonds.
6.1.3. Other PDI family members
Data on the function of other PDI familymembers in oxidative
folding are quite limited. ERp46 is highly expressed in endothelia
and essential for the secretion of at least three endothelial cell
survival factors during hypoxia as demonstrated by knockdown
experiments [103]. Consistent with a specific function in pro-
tecting cells against hypoxic insult, ERp46 is up-regulated during
hypoxia in cultured endothelial cells and primarily expressed in
microareas of known or putative hypoxia in the body [103].
ERp72 has been detected in complex with various substrate
proteins [89,91,104–108]. Although it comprises a b′ domain that
resembles the CNX/CRT-binding domain in ERp57 [10], the
enzyme does not work in concert with these lectin chaperones in
vivo [99], nor does it bind to model peptides in vitro [31].Together with PDI, P5 and other ER folding factors it is part of a
large complex that can be chemically cross-linked in living cells
[109] and may represent an ER chaperone network. Notably,
ERp72 often targets folding-impaired proteins, which results in
ER retention of the bound substrates [104,106–108] (see also
Section 7). The postmeiotic male germ cell-specific PDILT co-
immunoprecipitates with its lectin partner calmegin, but the
substrates of this novel, tissue-specific chaperone complex remain
to be identified [13]. Overexpression of TMX protects cells from
brefeldin A-induced cell death by an unknown mechanism that
depends on an intact active site in the enzyme [110]. In addition to
these examples, the expression of PDIp that binds to various
secretory proteins during their translocation into the ER [111] is
enriched in the pancreas [112,113] and under certain stress
conditions in the brain [114], indicating tissue-specific functions
of this enzyme. Finally, an interaction between ERp27 and the b′
domain of ERp57 has been detected but its potential influence on
substrate recognition and binding of CNX and CRT in vivo
remains unknown [115].
6.1.4. The role of PDIs during biosynthesis and secretion of
thyroglobulin
As mentioned above, certain substrates interact with more
than one PDI. Thyroglobulin, the precursor protein for thyroid
hormone synthesis, is a 660 kDa secretory glycoprotein with a
slow maturation rate and a textbook example of the cooperation
between different PDIs during folding of the same substrate.
PDI and ERp57 engage in mixed disulfides with thyroglobulin
simultaneously and co-translationally, and their release corre-
lates with the dissociation of thyroglobulin from other ER
chaperones. This indicates that PDI and ERp57 perform initial
cysteine oxidation as well as isomerization of pre-existing
disulfides. Interestingly, abrogation of the recruitment of ERp57
by castanospermine leads to inefficient and defective thyroglo-
bulin folding that cannot be compensated by PDI although more
of the disulfide-linked PDI adducts are trapped under these
conditions [93]. This implies that certain glycosylated folding
modules in thyroglobulin specifically require the assistance of
ERp57 in cooperation with CNX or CRT. In addition to PDI and
ERp57, chemical cross-linking has shown an interaction be-
tween ERp72 and thyroglobulin [105].
Efficient secretion of thyroglobulin depends on yet another
member of the PDI family, the dimeric and non-catalytic ERp29
[116,117]. Rather than being involved in the folding process
itself, ERp29 is thought to act as an escort protein [118] during
ER exit of folded thyroglobulin. Studies on the Drosophila
ortholog of ERp29 and a Drosophila cargo protein point to a
similar mechanism of action [119,120].
6.2. Special cases of protein folding and ER retention
6.2.1. Procollagen folding, assembly and quality control
The fibrillar collagens are secreted as procollagen trimers
that contain N- and C-terminal globular domains (N- and
C-propeptides) in addition to the central triple helix-forming
domain. For trimer formation, the C-propeptide domains of three
procollagen chains fold individually, and then interact to initiate
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procollagens in the ER is a complex process accompanied by a
number of post-translational modifications [121], most promi-
nently, the hydroxylation of proline residues.
PDI plays a vital role in many aspects of procollagen as-
sembly. Firstly, it is thought to be involved in the catalysis of
both intrachain and interchain disulfide bonds within and be-
tween the C-propeptide domains [122,123]. Secondly, as the
non-catalyticβ subunit of the enzyme prolyl 4-hydroxylase, PDI
is essential for proline hydroxylation [124]. Thirdly, PDI binds
to monomeric C-propeptides [125], an interaction that is not due
to mixed disulfides but is governed by the peptide-binding
properties of PDI [126].While this association may be important
for the recruitment of PDI to catalyze the formation of disulfide-
linked C-propeptide trimers, it clearly results in ER retention
of monomeric C-propeptides [126]. Thus, as a chaperone for the
C-propeptide, PDI is likely to contribute to quality control re-
tention of incompletely processed full-length procollagen.
Likewise, the chaperone function of PDI also causes some de-
gree of ER retention of overexpressed Ero1α [79].
6.2.2. Peptide loading onto MHC class I
MHC class I molecules present intracellularly derived
antigenic peptides on the cell surface for immune surveillance
by CD8-positive T cells. For the loading of these peptides in the
ER, correctly folded and disulfide-bonded HC (see Section
6.1.2) associates with β2-microglobulin (β2M) to generate a
heterodimer that is incorporated into the peptide-loading
complex (PLC). This multisubunit assembly is composed of
the HC/β2M dimer, the transporter associated with antigen
processing, the transmembrane protein tapasin, CRTand ERp57
[127]. The PLC is stabilized by multiple affinities between its
components including the lectin interaction between CRT and
the glycan in HC [128], the interaction between ERp57 andCRT,
and a stable interchain disulfide bond between the a domain
active site in ERp57 and cysteine 95 in tapasin [129]. ERp57
therefore plays a structural role in the PLC. More recently, also
PDI has been reported as a component of the PLC [84].
A principal function of the PLC is to promote the selection
of high-affinity peptide-MHC class I complexes. During this
process, redox regulation of the disulfide bond in the α2 domain
of HC, which is in close proximity to the peptide-binding groove
[130], is thought to play a key role [84,131–133]. Both PDI and
ERp57 have been trapped in transient mixed disulfides with α2
cysteines [84,131] and are required for the presentation of high-
affinity peptides on the cell surface [84,134].
A role of ERp57 in reducing the α2 disulfide bond has been
demonstrated in vitro and in vivo [131,135]. In cells that lack
functional tapasin, mixed-disulfide species between HC and
ERp57 become more prominent, and more HC is found in the
α2-reduced form [131]. Because tapasin deficiency also leads to
the release of HC from the PLC [131], the data suggest that in
wild-type cells ERp57 reduces primarily HC that has transiently
dissociated from the PLC. Similarly, only free, peptide-emptied
HC is susceptible to reduction by recombinant ERp57 in vitro
[135]. Therefore, ERp57 may function independently of its
structural role in the PLC to specifically recognize and reducethe α2 disulfide bond in suboptimally loaded, unstable MHC
class I molecules after their release from the PLC.
PDI may play the opposing role to ERp57 and re-oxidize HC,
since more α2-reduced HC is observed upon shRNA-mediated
depletion of PDI [84]. Moreover, depletion of peptides from the
ER also leads to more α2-reduced HC [84]. Because, in addition,
an intact peptide-binding site in the b′ domain of PDI is required
for maintaining the oxidized state of HC and for the selection of
high-affinity peptides [84], it is possible that PDI integrates the two
processes of peptide loading and α2 re-oxidation within the PLC.
What mechanism then could be involved in the re-recruitment
of reduced HCs into the PLC? By means of a cell-free system, the
disulfide-linked conjugate betweenERp57 and tapasin has recently
been shown to efficiently assemble all the components of the PLC
[136]. The conjugate-mediated assembly of the PLC was also
required for optimal peptide loading and selection. However, since
the assembly assay was performedwith whole cell lysates, the data
do not exclude PDI from the process of peptide delivery.
6.2.3. ERp44
ERp44 has been isolated as a disulfide-linked interactor of
Ero1α [137]. An unusual feature of ERp44 is the CXXS active-
site sequence that contributes to stabilize mixed-disulfide
complexes with Ero1α and other proteins [138]. Whereas PDI
binds to the active site of Ero1α, the single active-site cysteine of
ERp44 forms mixed disulfides with different exposed free
cysteines in Ero1α [138]. The best recognized role of ERp44 in
protein maturation is to act in thiol-mediated retention of nascent
proteins and overexpressed Ero1α in the early secretory pathway
[21,138]. Whether ER retention of endogenous Ero1α also
depends on ERp44 has not yet been addressed. Furthermore, the
new finding that ERp44 interacts with the transmembrane ER-
exit receptor ERGIC-53 that promotes its steady-state localiza-
tion to the ERGIC [19] suggests that rather than true retention in
the ER, ERGIC-to-ER retrieval of ERp44-substrate complexes
may be the primary mechanism of action. Thus, recognition by
ERp44 of incompletely folded proteins may add to the list of
quality control mechanisms in the ERGIC [139].
ERp44 is up-regulated during adipocyte [21] and B cell
differentiation [19]. In both cases, differentiation coincides with
secretion of a disulfide-linked multimeric protein— adiponectin
and secretory immunoglobulin M (IgM). Prior to secretion, the
controlled intracellular retention of both proteins by ERp44 is
required for faithful assembly. In the case of IgM, ERp44
cooperates with ERGIC-53 [19], while the secretion of higher-
order adiponectin complexes is regulated by the interplay
between ERp44 and Ero1α [21]. Ero1α is a preferred interaction
partner of ERp44 and can competitively release other proteins
from ERp44 [21,138].
7. The function of PDIs in retrotranslocation to the cytosol
An important function of the ER is to recognize terminally
misfolded proteins and target them for retrotranslocation to the
cytosol where they are polyubiquitinated and degraded by the
proteasome. This process is termed ER-associated degradation
(ERAD). Initial evidence for a role of PDIs in ERAD came from
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mutant, but not peptide-binding site-deleted Pdi1p could fully
support retrotranslocation of a cysteine-free model substrate
[140], this function arises from the chaperone activity of Pdi1p.
Similarly, the chaperone activity of human PDI is used for
dislocation of BACE457 from the ER [141], and in the un-
folding and dissociation of cholera toxin subunits before retro-
translocation [142]. However, based on in vitro experiments, the
oxidoreductase function of PDI does not seem to be important
in cholera toxin disassembly [142]. Thus, a glutathione buffer
mimicking ER conditions is capable of reducing the disulfide
bond between the A1 and A2 fragments of the toxin – a pre-
requisite for retrotranslocation of the A1 fragment – and PDI
addition gives only a slight rate enhancement of the process
[143]. Further experiments suggested that only reduced PDI is
able to bind cholera toxin, while oxidized PDI adopts a more
open conformation and shows no unfolding activity towards the
toxin [142]. Although this mechanism does not generally por-
tray a chaperone cycle of PDI [144], the finding that Ero1α
mediates the release of the toxin A1 chain from PDI [145]
supported the notion that PDI acts as a redox-driven chaperone
in retrotranslocation of cholera toxin. Conversely, oxidized PDI
has recently been found to be required and sufficient for ef-
ficient retrotranslocation of a model ERAD substrate devoid of
cysteines [146]. In analogy to cholera toxin, however, the sub-
strate was preferentially bound by reduced PDI.
While PDI-mediated unfolding makes cholera toxin A-chain
competent for retrotranslocation, ERp72 stabilizes the compact
fold of the toxin and antagonizes its dislocation to the cytosol
[147]. These activities are not restricted to cholera toxin, since
depletion of ERp72 increases the overall accumulation of
polyubiquitinated proteins in the cell when the proteasome is
inhibited, while depletion of PDI shows the opposite effect.
Likewise, a variant of thyroglobulin that is an ERAD substrate
was stabilized under conditions of PDI knockdown, but degraded
faster in ERp72-depleted cells [147]. Another secretion-incom-
petent thyroglobulin mutant pathologically accumulates in the
ERwhile being engaged in both disulfide-linked interactions with
ERp72 and, predominantly, non-covalent interactions with PDI
[106]. The misfolded mutant displays more cysteine thiols and
shows enhanced binding to ERp72 when compared to wild-type
thyroglobulin. Collectively, the data suggest that mixed-disulfide
interactions with ERp72 may actively interfere with PDI-
facilitated disposal of misfolded ER proteins.
Nonenveloped viruses exploit cellular pathways for entry
into the host cell and transport to the ER lumen, where mem-
brane penetration occurs to shuttle the viral DNA across the ER
membrane [148]. The structural rearrangements in the disulfide-
rich viral capsids that are a prerequisite for genome release in
part take place in the ERwhere they are promoted by PDIs. In the
case of mouse polyoma virus, ERp29 plays a key role by
triggering a conformational change in the VP1 capsid protein
that leads to increased hydrophobicity of the viral particle [149].
PDI is also required for infection and possibly acts downstream
of ERp29 to reduce or isomerize an interchain disulfide ring that
interconnects the subunits in the VP1 pentamer [150]. Con-
sistently, since one cysteine of these interchain-forming di-sulfides is not conserved in the related Simian virus 40 (SV40),
this virus shows a decreased requirement for PDI during
infection [150]. Instead, the VP1 subunits in SV40 are ex-
tensively cross-linked by a different set of interchain disulfide
bonds not found in polyoma virus. Very recently, ERp57-
catalyzed rearrangement of interchain to intrachain disulfide
bonds inVP1 of the SV40 envelopewas shown to be required for
infection [151]. Remarkably, ERp57 appeared to act on the virus
in a CNX/CRT-independent way. Whether subsequent ER
membrane penetration of nonenveloped viruses is directly per-
formed by viral capsid proteins [149,152,153], involves the
ERAD pathway [151,154] or both, is currently unclear.
8. Additional functions of PDIs in the ER
A number of functions of PDI in the ER that are not directly
related to protein maturation or retrotranslocation are known. In
analogy to its structural role in prolyl 4-hydroxylase, PDI forms
the β subunit of the microsomal triacylglycerol transfer protein
where it functions to keep the α subunit in a catalytically active,
non-aggregated conformation [155,156]. PDI also binds to
thyroid hormone and estradiol. The hormone-binding sites are
distinct from the peptide-binding site in PDI and owing to their
high abundance these complexes may function as cellular high-
capacity, low-affinity hormone reservoirs [157].
Evidence exists that PDI, as a potential link to the thiol–
disulfide system for oxidative protein folding, participates in
other ER redox systems. The first involves vitamin K epoxide
reductase (VKOR), a transmembrane protein of the ER
membrane that catalyzes the regeneration of vitamin K1 from
vitamin K1 2,3-epoxide. Vitamin K1 is an essential, redox co-
factor for the enzymatic carboxylation of glutamic acid
residues. The activity of VKOR is governed by a CIVC motif
[158] predicted to be embedded in the last transmembrane helix
of the enzyme [159]. Recently, it has been proposed that PDI
functions as a reductant of the active site in VKOR [160]. At
present though, it is unclear how PDI would gain access to the
presumably membrane-buried active site in VKOR. Secondly,
PDI can reduce dihydroascorbate (the oxidized, membrane-
permeable form of vitamin C) in vitro [161], and it has been
proposed that this activity plays a crucial role in the
accumulation of ascorbate in the ER [162]. Thirdly, recent
work revealed a regulatory role for PDI in NAD(P)H oxidase-
catalyzed production of reactive oxygen species in vascular
smooth muscle cells [163]. NAD(P)H oxidases are membrane
proteins at least a subfraction of which resides in the ER with
the active site exposed in the cytosol. Thus, redox-sensitive
regulation of these enzymes by PDI via a luminally oriented
binding site might contribute to the integration of the ER redox
state with cytosolic redox signaling.
Another intriguing function of certain PDIs is related to
homeostasis of the ER luminal calcium ion concentration
([Ca2+]ER). Ca
2+ pumps and channels in the ER membrane are
responsible for regulating [Ca2+]ER. In most tissues these
functions are carried out by sarco(endo)plasmic reticulum Ca2+
ATPase isoform 2b (SERCA2b) and by inositol 1,4,5-
trisphosphate receptor type I (IP3R1). Both proteins are subject
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luminal domain [164,165].
Ectopic expression of ERp57 in Xenopus oocytes potently
inhibits SERCA2b pump activity [165]. The interaction of ERp57
with the pump is mediated by CRT binding to the C-terminus of
SERCA2b, which likely occurs in a [Ca2+]ER-dependent fashion.
So, when [Ca2+]ER is high, active Ca
2+ import is stalled by the
recruitment of CRT – which itself binds Ca2+ – and ERp57 to
SERCA2b thus providing a direct feedback loop (Fig. 4).
Conversely, the regulation of IP3R1-mediated Ca
2+ leakage out
of the ER is achieved by ERp44 that physically blocks the release
channel only at low [Ca2+]ER (Fig. 4)[164]. Notably, ERp44 does
not bind IP3R1 through its active site, but via the C-terminal
region.
The luminal loops of both SERCA2b (L4) and of IP3R1
(L3V) that interact with ERp57 and ERp44, respectively,
comprise a conserved pair of cysteines (Fig. 4). It is plausible
that ER calcium homeostasis is controlled by a regulatory redox
switch mechanism involving these two cysteine pairs, althoughFig. 4. The roles of ERp57 and ERp44 in the regulation of [Ca2+]ER. Ca
2+
homeostasis in the ER is modulated by the interplay of the two multipass ER
transmembrane proteins SERCA2b and IP3R1 that pump Ca
2+ from the cytosol
into the ER lumen and release Ca2+ from the ER lumen into the cytosol upon
stimulation with inositol 1,4,5-trisphosphate (IP3), respectively (red arrows).
When [Ca2+]ER is low, ERp44 associates with a luminal loop in IP3R1, which
requires two loop cysteines in the thiol state (C-SH), and inhibits Ca2+ efflux
[164]. Under conditions of high [Ca2+]ER, the pump activity of SERCA2b is
down-regulated by the binding of ERp57 to a luminal loop in SERCA2b. The
down-regulation requires the active sites in ERp57 (not depicted) as well as the
presence of CRT that recruits ERp57 to SERCA2b [165]. The two conserved
cysteine pairs in the SERCA2b and IP3R1 luminal loops (depicted in brown)
potentially constitute redox switches, but their in vivo redox state is currently not
known (question marks, see text for further details).their in vivo redox state is currently unknown. Cysteine-
replacement mutants in the L4 loop of SERCA2b are more
active, presumably due to their inability to form a disulfide or
interact with ERp57 [165]. Although the binding of ERp57 to
SERCA2b depends on its active sites [165], it remains to be
established whether ERp57 is directly involved in oxidizing the
L4 cysteines or depends on a preformed disulfide bridge for
interaction. On the other hand, it is clear that both the binding of
ERp44 to IP3R1 and the inhibition of the channel by co-
expressed ERp44 depend on the two L3V cysteines being in the
reduced state [164]. However, a fraction of L3V likely exists in
the disulfide state, because treatment of cells with a reducing
agent results in increased cross-linking of IP3R1 to ERp44
[164]. It is therefore conceivable that regulated disulfide-bond
reduction in SERCA2b and IP3R1 leads to an increase in [Ca
2
+]ER. Since such redox regulation requires catalysis, it is
attractive to speculate that other PDI family members are in-
volved in the process.
9. Conclusions and perspectives
For decades, PDI itself was the only recognized family
member and in the first description of the PDI family in 1994
four members were known [166]. In this perspective, the recent
expansion of the family is remarkable. It would be surprising
though, if the thousands of proteins made in the ER did not have
specific needs in terms of folding and maturation, and if these
needs could all be fulfilled by a single or a few PDIs. It is therefore
to be expected that individual PDIs have different (types of)
substrates, and that they perform distinct tasks when cooperating
during the folding of proteins like thyroglobulin. The identifica-
tion of new endogenous substrates will be paralleled by the
challenge of investigating the specificity of PDIs for these
substrates in vitro. At the same time, a certain redundancy with
respect to substrate recognition has been observed in vivo. For
instance, when preventing substrate interaction by ERp57, other
PDIs have been found to associate with the particular substrates
investigated [99,167]. In addition, inactivation of ERp57 usually
only retards but does not seem to block the maturation of its
substrates.
To gain a better understanding of the multi-domain structures
found in most PDIs and the function of the different domains in
their natural context, structure determination of more PDIs is
needed. The similarity in domain orientation observed for Pdi1p
and ERp57bb′ with calsequestrin – a calcium storage protein
that contains three thioredoxin-like domains only very distantly
related to the PDIs at the sequence level [168] – is intriguing,
and it will be interesting to see if this is a general feature of the
PDIs. Crystallographic studies should be combined with NMR
spectroscopic investigation of interdomain dynamics in solu-
tion. In general, given the similarity between many redox-active
thioredoxin-like domains, the characterization of non-catalytic
domains could well hold the key to understanding the dif-
ferences between the human PDIs.
The cellular redox regulation of PDIs – and of the ER en-
vironment in general – is an exciting but complex topic with a
number of unresolved questions. One deals with the ability of
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another whether additional pathways for oxidation exist. Re-
cently, it has been proposed that oxidases of the QSOX family
[169], that quickly and efficiently introduce disulfides into
reduced unfolded proteins in vitro [170,171], could also do so in
the ER [80]. Here, the function of the PDIs would mainly be
restricted to isomerize non-native disulfides introduced by the
QSOXproteins.While the idea of such a pathway in the ER seems
appealing, further cell biological studies are clearly needed to
establish a potential function of the QSOX proteins in the ER,
especially since these proteins reside further along the secretory
pathway [172]. For instance, the trapping of mixed disulfides
between QSOX and folding intermediates in vivo could be
used to demonstrate QSOX-mediated thiol oxidation in the ER.
Another open question relates to how the ER deals with the
H2O2 generated by the Ero1 and potentially the QSOX pathway.
One possibility would be to employ glutathione or thioredoxin
peroxidases, but to date no such ER enzymes have been reported.
Does the ER harbor dedicated reductases? Among the PDIs,
ERdj5 is the strongest candidate since it contains several active
sites related to the CGPC motif in thioredoxin that are probably
more reducing than the regular CGHCmotif [173]. In analogy to
the thioredoxin reductase/thioredoxin system in the cytosol, the
potential function of ERdj5 in reducing disulfides could well
depend on an as yet unidentified reductase to maintain a reduced
fraction of ERdj5. Two other candidate reductases are the
selenoproteins Sep15 and SelM. Both have thioredoxin folds
and harbor an active-site selenocysteine in place of one cysteine,
a feature that renders them more reducing than PDIs [174]. The
determination of the in vivo redox characteristics and regulation
of Sep15, SelM and ERdj5 are interesting topics for future work.
In conclusion, the PDIs perform an impressive array of cel-
lular functions that we are just starting to take in. Even the well-
understood thiol–disulfide exchange reactions are not always
straightforward to grasp in the context of the cellular en-
vironment where they are regulated by various pathways. For
instance, although PDI is the best-known substrate of Ero1 it is
clear that its function is not restricted to oxidation. Underlying
the versatility of the PDIs is virtually one single domain type,
the thioredoxin fold, which has evolved to accommodate the
variety of functions displayed by the PDIs.
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